IP Library Granted Patent US 8,043,371
Granted Patent B2
US 8,043,371 · App. 11/025,293 · Granted Oct 25, 2011

Intraocular lenses having a visible light-selective-transmissive-region

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,043,371
App. No.
11/025,293
Granted
Oct 25, 2011
Kind
B2
Abstract

Intraocular lenses are provided having a visible-light selective transmissive zone defined therein. The visible light-selective transmissive zone can be located near the lens center and designed to reduce the transmission of any wave-length of visible light specifically light in the blue light region having wavelength between approximately 400λ to 550λ. In one embodiment he IOLs are made from acrylates and the light absorbing compound is a yellow dye.

Claims (4)

1. An intraocular lens (IOL) comprising an optic made from a structural polymer with a well centrally defined therein and at least one light absorbing dye which fills the well and is enclosed by the structural polymer as a discrete central region within the IOL such that the light absorbing dye does not contact either the eye's anatomical structures or physiological fluids, wherein the at least one light absorbing dye absorbs visible light between the wavelengths of 400λ and 550λ, wherein the light absorbing dye is a methine class dye having a concentration which is constant regardless of diopter strength, and wherein the discrete central region has a diameter less than about 4.5 mm.

2. The IOL according to claim 1 wherein the structural polymer is selected from the group consisting of acrylates, silicones, hydrogels, and acrylic-silicone hybrids.

3. The IOL of claim 1 further comprising a ultraviolet light absorbing compound.

4. The IOL according to claim 3 wherein the ultraviolet light absorbing compound is a benzophenone or benzotriazole.

Assignments (1)
CHANGE OF NAME Recorded Sep 25, 2018
From: ABBOTT MEDICAL OPTICS INC.
To: JOHNSON & JOHNSON SURGICAL VISION, INC.
Reel/Frame 047150/0976 →